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INTRODUCTION: Few data exist to help physicians how to use diuretics to provide the greatest 
symptomatic benefit with the least adverse effect and to select which subset of patients 
require a more aggressive diuretic strategy and monitorization.  
OBJECTIVES: The aim of this study is to identify early predictors of diuretic response in a 
selected group of patients with acutely decompensated chronic heart failure (ADCHF). 
MATERIAL AND METHODS: Observational, prospective study including 100 patients with 
ADCHF. 
RESULTS: Mean ± standard deviation (SD) age was 76,0 ± 10,9 years. Sixty-one patients were 
female. Due to the persistence of congestive signs after three days of inpatient treatment, 16 
(16%) patients maintained or increased i.v. furosemide dose (slow diuretic response, SDR) 
during the study period. The other 84 patients had greater congestion relief and decreased i.v. 
furosemide dose or switched furosemide to oral route (fast diuretic response, FDR). Admission 
day factors predicting SDR were: higher levels of pUr (mean ± SD, 69,6 ± 20,9 vs 52,5 ± 19,8, p 
= 0,002); higher levels of pUr / pCr ratio (mean ± SD, 58,3 ± 15,2 vs 49,6 ± 15,1, p = 0,036); 
higher levels of albuminuria (median [IQR], 131,5 [396,9] vs 47,1 [143,6], p = 0,011); higher 
levels of RDW (median [IQR], 16,0 [1,9] vs 15,1 [1,5], p = 0,039); lower levels of HgB (mean ± 
SD, 11,5 ± 1,8 vs 12,6 ± 2,1, p = 0,04); and higher levels of hsTnT (median [IQR], 0,05 [0,05] vs 
0,03 [0,03], p = 0,026). By multivariate analysis the strongest independent early predictors of 
SDR were: pUr (OR [95%CI], 1,04 [1,01 – 1,07], p = 0,006), and red-cell distribution width (RDW) 
(OR [95%CI], 1,47 [1,07 – 2,02], p = 0,018). During the first three days of hospitalisation the 
strongest independent factor associated with SDR was NTProBNP decrease by less than 30% or 
increase from day 1 to day 3 (OR [95%CI], 4,84 [1,14 – 20,55], p = 0,032). Use of high dose 
spironolactone is associated with FDR (OR [95%CI], 0,17 [0,03 – 0,85], p = 0,031). 
CONCLUSIONS: High RDW and high levels of pUr at admission are strong predictors of slower 
diuretic response. No change or increase in NTproBNP in the first three days of treatment is 
associated with slower diuretic response. On the other hand, the use of high dose 
spironolactone is associated with faster diuretic response. 
